|
Mr. Shuster is a very successful business person with broad and extensive experiences in the biotechnology industry. He is currently President and CEO of Kemia, Inc. Before he joined Kemia, Inc., Mr. Shuster served as the CFO for Pharmacopeia and Human Genome Sciences where he led successful IPOs for both companies. Mr. Shuster also held several executive management positions at Invitrogen Corporation, including COO. In addition to his position as CFO at Pharmacopeia, he also served as the COO of Pharmacopeia Labs. Mr. Shuster previously held executive positions at Human Genome Sciences and Microbiological Associates (now BioReliance). In earlier years, Mr. Shuster served for the Boston Consulting Group and United States Senate Budget Committee. Mr. Shuster obtained an MBA from Stanford University Graduate School of Business and a BA in Economics from Swarthmore College. | 